Intervention Review

You have free access to this content

Ivermectin for onchocercal eye disease (river blindness)

  1. Henry OD Ejere1,*,
  2. Ellen Schwartz2,
  3. Richard Wormald3,
  4. Jennifer R Evans3

Editorial Group: Cochrane Eyes and Vision Group

Published Online: 15 AUG 2012

Assessed as up-to-date: 2 APR 2012

DOI: 10.1002/14651858.CD002219.pub2

How to Cite

Ejere HOD, Schwartz E, Wormald R, Evans JR. Ivermectin for onchocercal eye disease (river blindness). Cochrane Database of Systematic Reviews 2012, Issue 8. Art. No.: CD002219. DOI: 10.1002/14651858.CD002219.pub2.

Author Information

  1. 1

    Hode Internal Medicine, Texas, USA

  2. 2

    Institute of Ophthalmology, London, UK

  3. 3

    London School of Hygiene & Tropical Medicine, Cochrane Eyes and Vision Group, ICEH, London, UK

*Henry OD Ejere, Hode Internal Medicine, 125 South Park Drive, Suite F, Brownwood, Texas, 76801, USA.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 15 AUG 2012


Cited in:


This article has been cited by:

  1. 1
    Ayokunle T Abegunde, Richard M Ahuja, Nkem J Okafor, Doxycycline plus ivermectin versus ivermectin alone for treating onchocerciasis, The Cochrane Library,